RiVax®-Vaccinated NHP survival was statistically significantly correlated with an epitope-specific serum assay ("EPICC") prior to challenge Correlates of protection are essential to support approval via the FDA "Animal Rule" PRINCETON, N.J., Dec. 20, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on… Read More..

  The multicenter REFINE-ALS prospective trial for Radicava® (Edaravone), sponsored by Mitsubishi Tanabe Pharma America (MTPA), has been conducted in collaboration with Massachusetts General Hospital and Harvard Medical School Dr. James Berry, Director of Massachusetts General Hospital (MGH) Neurological Clinical Research Institute (NCRI), shared the interim analysis from the REFINE-ALS… Read More..

FRISCO, TX, Dec. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Verde Bio Holdings, Inc. (OTCQB: VBHI), a growing oil and gas company, today issued its second quarter shareholder update, along with its 10-Q filing with the highlights of the Quarter and what is in store for the future. The… Read More..